AU8282198A - Process for synthesizing carbapenem side chain intermediates - Google Patents

Process for synthesizing carbapenem side chain intermediates Download PDF

Info

Publication number
AU8282198A
AU8282198A AU82821/98A AU8282198A AU8282198A AU 8282198 A AU8282198 A AU 8282198A AU 82821/98 A AU82821/98 A AU 82821/98A AU 8282198 A AU8282198 A AU 8282198A AU 8282198 A AU8282198 A AU 8282198A
Authority
AU
Australia
Prior art keywords
compound
accordance
formula
produce
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU82821/98A
Other versions
AU731586B2 (en
Inventor
Michael S. Ashwood
Karel M. J. Brands
Mark Cameron
Ian F. Cottrell
Anthony J. Davies
Ulf H. Dolling
Ronald B. Jobson
John M. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810184.3A external-priority patent/GB9810184D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU8282198A publication Critical patent/AU8282198A/en
Application granted granted Critical
Publication of AU731586B2 publication Critical patent/AU731586B2/en
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. Request to Amend Deed and Register Assignors: MERCK & CO., INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)

Description

WO 99/02531 PCT/US98/13738 -1 TITLE OF THE INVENTION PROCESS FOR SYNTHESIZING CARBAPENEM SIDE CHAIN INTERMEDIATES 5 BACKGROUND OF THE INVENTION The present invention relates to the synthesis of carbapenem side chains, and in particular, to side chains or portions thereof containing a pyrrolidine group, which is bonded to the carbapenem nucleus through a thioether linkage. Typically, the pyrrolidine is a portion of the side 10 chain, and is substituted at the two position with any of a variety of substituents. Conventionally, these intermediate compounds are prepared from a 4-hydroxyproline derivative of the formula: HO
CONR
1
R
2 N 15 R Such synthetic schemes typically require the extensive use of protecting groups. Similarly, a method of converting trans-4-hydroxy-L-proline to a thiolactone of the formula: 20 0 S N
C(O)CH
3 has been described. However, this thiolactone is unsuitably protected for synthesis of carbapenem antibiotics.
WO 99/02531 PCT/US98/13738 -2 EP 551 993 Al published on July 21, 1993 relates to a synthesis which utilizes active esterifying agents and base, followed by treatment with hydrogen sulfide, or an alkali metal salt of hydrogen sulfide, and base. 5 The present invention is an improvement over these other processes, utilizing a sulfide source which surprisingly improves the process when commercial quantities are synthesized. SUMMARY OF THE INVENTION 10 A process for synthesizing a compound of the formula 1: PINI N* ' 0 S 1 is described wherein P is a protecting group 15 comprising (a) reacting a compound of formula 2: HO,,,, N CO 2 H P 20 2 wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of formula 3: WO 99/02531 PCT/US98/13738 -3 HO,, N O I U 0 3 (b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4: 5 H 3 C S O 3 ,,,, N COP I 0I P 4 and (c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1. 10 More particularly, the process described herein relates to a process for producing a compound of the formula 5: HS
C(O)NR
1
'R
2 N P 5 15 WO 99/02531 PCT/US98/13738 -4 wherein P is a protecting group; R1 and R 2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or 5 substituted with from 1-3 groups selected from the group consisting of: C1-4 alkyl, C1-4 alkoxy, C 1-4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH 2 , NHC1-4 alkyl, N(C1-4 alkyl)2, SO3H, CN,
NHC(O)C
1
-
4 alkyl, SO2NH 2 , SO 2 C1- 4 alkyl, aryl and heteroaryl; 10 comprising: (a) reacting a compound of the formula 2: HO,,, N C0 2 H P 2 wherein P is as previously defined with diphenylphosphinic chloride to 15 produce a compound of the formula 3: HO,,,, N O , ,o, 0 3 (b) reacting compound 3 with methanesulfonyl chloride to 20 produce a compound of formula 4: WO 99/02531 PCT/US98/13738 -5 H 3 CS 0 3 ,,, N COP U Ui 4 (c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1: 5 0 S 1 and 10 (d) reacting compound 1 with NHR 1
R
2 wherein R 1 and R 2 are as previously defined to produce a compound of formula 5. DETAILED DESCRIPTION OF THE INVENTION The invention is described using the following definitions 15 unless otherwise specified. Alkyl and the alkyl portions of substituent groups include monovalent hydrocarbon chains containing from 1-4 carbon atoms which are straight or branched as appropriate. Aryl refers to 6-10 membered mono- and bicyclic ring 20 systems, containing carbon atoms with alternating (resonating) double bonds. Preferred aryl groups are phenyl and naphthyl. Heteroaryl refers to aromatic 5-10 membered mono- and bicyclic ring systems, containing from 1-4 heteroatoms, O, S or N.
WO 99/02531 PCT/US98/13738 -6 Preferred nitrogen containing monocyclic heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl and 1, 2, 4-triazolyl. Preferred heteroaryl groups containing oxygen as the only heterotom include furanyl. Preferred heteroaryl groups 5 containing sulfur as the only heterotom include thienyl. Preferred bicyclic heteroaryl groups include benzthiazolyl, benzimidazolyl, quinolinyl and isoquinolinyl, indolyl and isoindolyl. When substituted, the aryl and heteroaryl groups may be substituted with 1-3 groups selected from the group consisting of: C1-4 10 alkyl, C1-4 alkoxy, C1-4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl,
NH
2 , NHC 1
-
4 alkyl, N(C1- 4 alkyl)2, NHC(O)C1- 4 alkyl, SO3H, CN, SO2NH 2 , SO2C1-4 alkyl, aryl and heteroaryl. When necessary, the substituents which are optionally present on aryl and heteroaryl can be in protected form. 15 Examples of suitable protecting groups include the following without limitation: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyl oxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2 trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 20 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethyl silyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C-lo alkylphosphoryl, diarylphosphoryl and di-ar-C, 1 0 alkylphosphoryl. Preferred silyl 25 protecting groups are trimethylsilyl and triethylsilyl. Preferred carboxyl protecting groups are p-nitrobenzyl and allyl. Preferred phosphoryl based protecting groups include diisopropylphosphoryl. Many other suitable hydroxyl and carboxyl protecting groups are known in the art. See, e.g., Greene, T. W., et al. Protective 30 Groups in Organic Synthesis, John Wiley & Sons, Inc., 1991. P represents a protecting group on the proline nitrogen atom. Thus, in one aspect of the invention, P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenyl silyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitro- WO 99/02531 PCT/US98/13738 -7 benzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl) 5 ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C.
10 alkylphosphoryl, diarylphosphoryl and di-ar-Cl- 1 0 alkylphosphoryl. More particularly, P represents a protecting group which is selected from the group consisting of: t-BOC, diisopropylphosphoryl and 10 p-nitrobenzyloxycarbonyl. Most particularly, P represents diisopropylphosphoryl. Compound 2 used herein as a starting material is N protected trans-4-hydroxy-L-proline. The 2-carboxyl group is activated using the compound diphenylphosphinic chloride, which is reacted with 15 compound II in a solvent in the presence of excess base. Solvents which are useful herein include dichloromethane, acetonitrile, toluene, fluorobenzene, tetrahydrofuran, or mixtures thereof. Bases which are useful for this reaction include trialkylamines. Preferred trialkylamines include diisopropylethylamine (DIPEA) and triethylamine. 20 Typically an amount of diphenylphosphinic chloride which is about equimolar to the starting compound can be used. The reaction between compound 2 and diphenylphosphinic chloride is typically run at reduced temperature, below about 0OC to as low as about -40 0 C. Preferably, the reaction temperature is maintained at about -10 0 C. 25 Compound 3, with the diphenylphosphinyloxycarbonyl group at position two, is reacted with methanesulfonyl chloride (MsC1) to produce compound 4. This reaction is conducted in a solvent, in the presence of a slight molar excess of pyridine, collidine, lutidine and the like, using a slight molar excess of MsC1. This mesylation reaction may 30 be conducted over about 1-4 hours, at a reduced temperature, e.g., about 0OC to as low as about -40oC. Preferably, the reaction temperature is maintained at about -10 0 C. Compound 4 is thereafter combined with an alkali metal sulfide or non-alkali metal sulfide and water to form the thiolactone 1.
WO 99/02531 PCT/US98/13738 -8 Essentially the reaction can be conducted at about -10 0 C to about room temperature. Preferably the sulfide and water are added quickly, and the reaction is aged for several hours at ambient temperature. As used herein, "alkali metal sulfide" refers to the group I 5 metal sulfides, such as the sulfides of sodium and potassium. Preferably the alkali metal sulfide is Na 2 S. As used herein, "non-alkali metal sulfides" and "alkaline earth metals" are used interchangeably to include the group II alkaline earth metal sulfides selected from the group consisting of: magnesium, 10 calcium and barium. Preferred are calcium and barium. The preferred non-alkali metal sulfide, most notably CaS, provides an unexpected advantage in that side products of the reaction have low solubility in water, and thus can be removed as a precipitate. In a preferred aspect of the process described herein, the 15 amine HNR 1
R
2 is m-aminobenzoic acid. In another preferred aspect of the process, the compound of formula 5 is reacted with an acid to produce a compound of formula 6: HS CNN C(O)NR 1
R
2 N H 6 20 More particularly, a compound of formula 2': H O,, O N_0 2 H P(O)(OiPr) 2 2' 25 is reacted with diphenylphosphinic chloride to produce a compound of formula 3': WO 99/02531 PCT/US98/13738 -9 HO,,, C02P(O)(Ph)2 N P(O)(OiPr) 2 3' compound 3' is reacted with mesyl chloride to produce compound 4': 5 MsO,, M N- C0 2 P(O)(Ph) 2 N P(O)(OiPr) 2 4' compound 4' is reacted with a member selected from the group consisting of: Na 2 S, K2S, CaS and BaS to produce a compound of formula 1': 10 (iPrO) 2 P(0) N' 0 S 1' compound 1' is reacted with m-aminobenzoic acid to produce 5': WO 99/02531 PCT/US98/13738 -10 C02H HS N C(0)NH P(O)(OiPr)2 5' and compound 5' is reacted with acid to produce a compound of formula 6': 5 C02H HS -- N C(0) NHd 'N H 6' or a salt or solvate thereof. 10 In a preferred aspect of the invention, the thiolactone compound 1 is reacted with the amine HNR'R 2 in the presence of an organic acid to produce compound 5. Examples of suitable organic acids include formic acid, acetic acid and propionic acid. Most preferably, the 15 reaction is conducted in the presence of acetic acid. After the conversion of compound 4' to compound 1', the latter is combined with ammonia or a primary or secondary amine to form compounds of formula 5', which can be deprotected to give compound 6' or salt thereof. In the isolation of 6' solvents, such as C,-s 20 alcohols, C1-3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others may be added to improve crystallization, or otherwise facilitate isolation.
WO 99/02531 PCT/US98/13738 -11 Also, addition of a trialkyl or triaryl phosphine, e.g., tri-n-butylphosphine, at this stage may be useful in reducing the formation of disulfides corresponding to compound 6' and/or improving the rejection of other impurities. 5 Most primary and secondary amines HNR 1
R
2 wherein R 1 and/or R 2 represent H, aryl or heteroaryl react with compound 1 upon slight heating. Generally, the reaction proceeds from about RT to about 100oC over a few minutes to several hours. The acid that is used to convert compound 5' to compound 10 6' can be varied within wide limits. For example, concentrated HCI can be used and is preferred. The invention described herein can be conducted in essentially a single reaction vessel, thus allowing for economical production of compounds 6' from compound 2. 15 The invention is further illustrated with the following non limiting examples. EXAMPLE ONE (1 S, 4S)-5-DIISOPROPYLPHOSPHORYL-2-THIA-5 20 AZABICYCLO [2.2.11HEPTAN-3-ONE HO, Cdiphenylphosphinic NN-CO2 H chloride Nv P(O)(OiPr) 2 1-2 HO/ % methanesulfonyl CO2 chloride P(O)(OiPr) 2 1-3 WO 99/02531 PCT/US98/13738 -12 MsO, CO S aSlurry N 1-4 /S P(O)(OiPr) 2 (iPrO) 2 ()Pl 0 S 1-1 5 The following starting materials were utilized: Starting Material Quantity Diisopropylphosphoryl 5.0 g, 16.93 mmol hydroxyproline Diisopropylethylamine 6.34 mL, 36.44 mmol Diphenylphosphinic 3.36 mL, 17.61 mmol chloride Pyridine 1.48 mL, 18.29 mmol Methanesulfonyl chloride 1.43 mL, 18.46 mmol Calcium sulfide 1.49 g, 20.66 mmol Dichloromethane 100 mL Water 350 mL The mesylate mixed anhydride was formed according to WO 97/06154 published on February 20, 1997, incorporated herein by 10 reference, and stirred with cooling at -15oC for 15 min. Calcium sulfide (1.49 g) was added as a solid and washed with water (30 mL), resulting in a three phase reaction mixture. The mixture was stirred rapidly and the cooling bath removed, allowing the mixture to reach room temperature.
WO 99/02531 PCT/US98/13738 -13 The solids quickly went into solution, and a white solid precipitate was formed. The mixture was stirred for 45 min and then filtered through a coarse filter. The solid on the filter was washed with dichloromethane 5 and the filtrate separated. The organic layer (approx. 200 mL) was washed with 1 M HCI (50 mL), and 8% NaHCO 3 (50 mL). The aqueous bicarbonate layer was back extracted and the combined extracts were washed with brine and the layers weighed. The presence of the title compound (4.04 g) was 10 confirmed by HPLC. EXAMPLE TWO H O,, OH diphenylphosphinic chloride I t-BOC 0 2-2 H ,,,O II methanesulfonyl O- F chloride t-BOC O 0 2-3 15 WO 99/02531 PCT/US98/13738 -14 Ms O,, 0- ICaS N 1/\ H 2 0 t-BOC 0 2-4 t-BOC 0 S 2-1 A. Synthesis of trans-N-t-butoxycarbonyl-2 diphenylphosphinvloxycarbonyl-4-hydroxy-L-proline HO H 0DIPEA OH dry THF -20 0 C N I diphenylphosphinic t-BOC O chloride 2-2 HO O t-BOC O 5 2-3 A solution of compound 2-2 (35.0 g, 151 mmol.) and DIPEA (60 mL, 344 mmol) in dry THF (1.0 L) was combined over 20 min with a WO 99/02531 PCT/US98/13738 -15 solution of diphenylphosphinic chloride (37.5 g, 155 mmol) in THF (50 mL) at -20oC. The reaction mixture was stirred at -20oC for 90 minutes to produce compound 2-3, which can be isolated and characterized or used in the next part without isolation. 5 B. Synthesis of trans-N-t-butoxycarbonyl-2-diphenylphosphinyl oxycarbonyl-4-methanesulfonyloxy-L-proline HO,o .. methanesulfonyl O P chloride N t-BOC 0 2-3 Ms OfO OP t-BOC O0 2-4 10 Without isolation and characterization, after stirring the reaction mixture from part A for 90 minutes at -20oC, pyridine (13.0 mL, 161 mmol) was added followed by a solution of methanesulfonyl chloride (19.8 g, 171 mmol) in THF (50 mL) over 15 minutes. The reaction 15 mixture was stirred at -20oC for 2 hours and allowed to warm to -5 0 C over an additional 30 minutes producing compound 2-4. The methanesulfonyl substituted compound can be isolated and characterized, or used in the next reaction without isolation and characterization.
WO 99/02531 PCT/US98/13738 -16 C. Synthesis of N-t-butoxycarbonyl-2-thia-5-azabicyclo[2.2.1]heptan 3-one MsO,, O \CaS/H 2 0 N Slurry t-BOC 0 2-4 t-BOC ll O S 2-1 5 After allowing the reaction from part B to warm to -5oC, a slurry of CaS (45.0 g, 187 mmol) in H20 (60 mL) is added in one portion. The mixture is allowed to warm to room temperature and is stirred for 6 hrs. The resulting suspension is filtered and the filtrate is 10 then partitioned between toluene and water. The organic layer is washed with HC1 (2.0 M), NaHCO3 (1.0 M) and brine, dried over MgSO4 and concentrated in vacuo. EXAMPLE THREE 15 HS tBOC N 0 _____ t-BOCN' C(0)NR'R 2 S N 2-1 1 t-BOC 3-5 WO 99/02531 PCT/US98/13738 -17 The thiolactone 2-1 from Example Two without isolation, can be combined with the amine shown below in column one to produce the cis N-protected 4-thiol substituted proline derivative shown below in column two. 5 TABLE ONE Amine Product (3) (3-1) HS NH4Cl
C(O)NH
2 N I t-BOC 3-5-1 (3-2) HS
NH
2 C(0)NH- j N I I I t-BOC 3-5-2 (3-3)
NH
2 HS C(0)NH/
SCO
2 H
CO
2 H 2 t-BOC 3-5-3 WO 99/02531 PCT/US98/13738 -18 (3-4) HSo C(O)NH CO2H H2N S CO2H I t-BOC 3-5-4 (3-5) HS
NH
2 HS C(O)NH N CO 2 H / CO 2 H K(O)(OiPr) 2 C02H 3-5-5 (1) 4.0 eq. of NH 4 Cl in Et 3 N; solvent CH3OH; reaction time: 30 min at RT; (2) 1.25 eq. of aniline; solvent toluene; reaction time: 5 2 hrs at 100'C; (3) 1.25 eq. of 3-aminobenzoic acid; solvent toluene; reaction time: 2 hrs at 100 0 C; (4) 1.25 eq. of 5-amino-2-carboxythiophene; solvent toluene; 2 hrs at 100oC; 10 (5) P represents diisopropylphosphoryl. (iPr = isopropyl). EXAMPLE FOUR Using the procedures set forth in Example Two, Part A, the 15 compounds of column one are reacted with diphenylphosphinic chloride to produce the compounds in column two.
WO 99/02531 PCT/US98/13738 -19 TABLE TWO H O,,,,. HHO, "" _./.CO02P(O)(Ph) 2
CO
2 H N NN 2 Ph = phenyl 4-2-1 HO,,,,, HO,,,,,
CO
2 H
CO
2 P(o)(Ph) 2 N N 00 00 4-2-2 4-3-1 HO,,,, H O,,,,
-"CO
2 H
CO
2 P(O)(Ph) 2 CN N 0/ ,,0 0/10 4-2-3 4-3-3 SUBSTITUTE SHEET (RULE 26) WO 99/02531 PCT/US98/13738 -20 EXAMPLE FIVE Using the procedures set forth in Example One, Part B, the compounds of column one are reacted with methanesulfonyl chloride to 5 produce the compounds in column two. TABLE THREE 5-4-1 M SO,,, M ,.... C02P(0)(Ph) 2 4-3-1 N O/O
NO
2 Ph = phenyl 5-4-2 4-3-2 MsO,,,,
CO
2 P(0)(Ph) 2 N 0O WO 99/02531 PCT/US98/13738 -21 5-4-3 4.- 3 -3 Ms O,,,, 4-3- MCO 2 P(O)(Ph) 2 N EXAMPLE SIX Using the procedures set forth in Example Two, Part C, the 5 compounds of column one are reacted with CaS in water to produce the compounds in column two. TABLE FOUR 6-1-1
NO
2 5-4-1 ON 0
S
WO 99/02531 PCT/US98/13738 -22 6-1-2 5-4-2 0 O~N 0 0
S
6-1-3 5-4-3 O0 joAN/- O EXAMPLE SEVEN 5 Using the procedures set forth in Example Three, the compounds of column one are reacted with the amine in column two to produce the compounds in column three.
WO 99/02531 PCT/US98/13738 -23 TABLE FIVE Amine NHR 1
R
2 Pyrrolidine 7-5-1 1 HS (1)
C(O)NH
2 6-1-1 NH4C1I N
OO
NO
2 7-5-2 1 (2) HS
NH
2 C(O)NH-Ph 6-1-1 N 00 I
NO
2 Ph = Phenyl 7-5-31 (3) HSc
NH
2 C(O)NH 6-1-1
CO
2 H 0
CO
2 H C02H NO 2 WO 99/02531 PCT/US98/13738 -24 7-5-4 1 (4 ) H S C C(O)NH/ 6-1-1
H
2 N- N 2 H C2H S CO2H OO2
SNO
2 7-5-5 1 HS (1) 6-1-2 C(O)NH 2 NH4C I O O 7-5-6 1 (2) HS 6-1-2 NH 2 C(O)NH-Ph 00\ Ph = Phenyl 7-5-7 1 (3) HS 6-1-2
NH
2 N C(0)NH Co02H 0ON CO 2
H
WO 99/02531 PCT/US98/13738 -25 7-5-8 1 (4) HSC()NH 6-1-2 H 2 N CO2H N C(O)NH S CO 2 H HN s I00 2 H 0 N0 7-5-9 1 HS (1)
C(O)NH
2 6-1-3 NH4C1 N 0 7-5-10 1 (2) HS
NH
2 ' C(O)NH-Ph 6-1-3 N Ph = Phenyl 7-5-11 1 (3) HS
NH
2 C(0)NH / 6-1-3 O
CO
2 HO O CO 2
H
WO 99/02531 PCT/US98/13738 -26 (4) 7-5-12 1 HS4 6-1-3 H 2 N CO 2 H S N C(O)NH CO 2 H _C02H_0_0_C020 (3) 7-5-13 1
NH
2 HS 1-1 C(0)NH /
CO
2 H
CO
2 H k(O)(OiPr)2 1: Tri-n-butylphosphine may be added. While certain preferred embodiments have been described 5 herein in detail, numerous alternative embodiments are contemplated as falling within the scope of the invention.

Claims (39)

1. A process for synthesizing a compound of the formula 1: PN 0 S 5 1 wherein P is a protecting group, comprising (a) reacting a compound of the formula 2: 10 HO,,, N CO 2 H I P 2 wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3: 15 H O,, 3 3 WO 99/02531 PCT/US98/13738 -28 (b) reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4: H 3 CS0 3 ",,. N O P 0 0 4 ,and 5 (c) combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
2. A process of producing a compound of the formula 5: 10 HS C(O)NR'R 2 N P 5 wherein P is a protecting group; 15 R 1 and R 2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: C1-4 alkyl, C1-4 alkoxy, C 1-4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH2, NHC 1-4 alkyl, N(C1-4 alkyl)2, SO3H, CN, 20 NHC(O)C1- 4 alkyl, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl; comprising: (a) reacting a compound of the formula 2: WO 99/02531 PCT/US98/13738 -29 HO,, N CO 2 H P 2 wherein P is as previously defined with diphenylphosphinic chloride to 5 produce a compound of the formula 3: HO,,.. N O 3 (b) reacting compound 3 with methanesulfonyl chloride to 10 produce a compound of formula 4: H 3 CSO 3,, 4,,.. N 4 WO 99/02531 PCT/US98/13738 -30 (c) combining compound 4 with an alkali metal sulfide or non alkali metal sulfide in water to produce a compound of formula 1: PN 0 S 1 5 and (d) reacting compound 1 with NHR 1 R 2 wherein RI and R 2 are as previously defined to produce a compound of formula 5.
3. A process in accordance with claim 1 wherein 10 P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2 trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 15 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2 (trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C-,o alkylphosphoryl, diarylphosphoryl and di-ar-CI- 10 alkylphosphoryl. 20
4. A process in accordance with claim 3 wherein P is selected from t-BOC, p-nitrobenzyloxycarbonyl and diisopropylphosphoryl. 25
5. A process in accordance with claim 4 wherein P represents diisopropylphosphoryl.
6. A process in accordance with claim 2 wherein 1 and NHR'R 2 are reacted to produce a compound of formula 5 in the presence 30 of an organic acid. WO 99/02531 PCT/US98/13738 -31
7. A process in accordance with claim 6 wherein the organic acid is selected from formic acid, acetic acid and propionic acid. 5
8. A process in accordance with claim 6 wherein 1 and NHR 1 R 2 are reacted in an organic solvent.
9. A process in accordance with claim 8 wherein the organic solvent is methylene chloride. 10
10. A process in accordance with claim 1 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base. 15
11. A process in accordance with claim 3 wherein the base is a trialkylamine.
12. A process in accordance with claim 11 wherein the trialkylamine is selected from the group consisting of 20 diisopropylethylamine and triethylamine.
13. A process in accordance with claim 1 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base. 25
14. A process in accordance with claim 13 wherein the base is selected from the group consisting of pyridine, collidine and lutidine. 30
15. A process in accordance with claim 1 wherein compound 4 is reacted with a non-alkali metal sulfide to produce a compound of formula 1. WO 99/02531 PCT/US98/13738 -32
16. A process in accordance with claim 15 wherein the non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10oC to about room temperature. 5
17. A process in accordance with claim 1 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p-nitrobenzyloxycarbonyl. 10
18. A process in accordance with claim 2 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base.
19. A process in accordance with claim 18 wherein the 15 base is a trialkylamine.
20. A process in accordance with claim 19 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine. 20
21. A process in accordance with claim 2 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base. 25
22. A process in accordance with claim 19 wherein the base is selected from the group consisting of pyridine, collidine and lutidine.
23. A process in accordance with claim 1 wherein the 30 non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10oC to about room temperature. WO 99/02531 PCT/US98/13738 -33
24. A process in accordance with claim 2 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p nitrobenzyloxycarbonyl. 5
25. A process in accordance with claim 2 wherein NHR 1 R 2 is selected from the group consisting of: NH 2 NH 2 NH4C1, H2NCO 2 H and _ C02 H C02 H and
26. A process in accordance with claim 15 wherein the 10 non-alkali metal sulfide is selected from a sulfide of calcium, barium and magnesium.
27. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of calcium sulfide. 15
28. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of barium sulfide.
29. A process in accordance with claim 1 wherein: 20 P represents diisopropylphosphoryl and compound 4 is reacted with CaS in water to produce a compound of formula 1.
30. A process in accordance with claim 1 wherein: P represents diisopropylphosphoryl and compound 4 is reacted with Na 2 S 25 in water to produce a compound of formula 1.
31. A process in accordance with claim 2 wherein the amine HNR 1 R 2 is m-aminobenzoic acid. WO 99/02531 PCT/US98/13738 -34
32. A process in accordance with claim 2, further comprising reacting a compound of formula 5 with an acid to produce a compound of formula 6: HS HS C(O)NR' R 2 N H 5 6
33. A process in accordance with claim 32 in which trialkyl or triarylphosphines is optionally added. 10
34. A process in accordance with claim 33 in which the trialkylphosphine is tri-n-butylphosphine.
35. A process in accordance with claim 32 in which a solvent selected from the group consisting of C,- 5 alcohols, C,- 3 alkanoic 15 acids, toluene, acetonitrile, ethyl acetate and others is optionally added.
36. A process in accordance with claim 2, wherein a compound of formula 2': HOI, C0 2 H N P(O)(OiPr) 2 20 2' is reacted with diphenylphosphinic chloride to produce a compound of formula 3': WO 99/02531 PCT/US98/13738 -35 HO,,,, O C0 2 P(O)(Ph) 2 N P(O)(OiPr) 2 3' compound 3' is reacted with mesyl chloride to produce a compound of formula 4': 5 MsO,, C0 2 P(O)(Ph) 2 N P(O)(OiPr) 2 4' compound 4' is reacted with a member selected from the group consisting of: Na 2 S, K2S, CaS and BaS to produce a compound of formula 1': 10 (iPrO) 2 P(0) .N' 0 S 1' compound 1' is reacted with m-aminobenzoic acid to produce 5': WO 99/02531 PCT/US98/13738 -36 C0 2 H HS N C(O)NH N P(O)(OiPr) 2 5' and compound 5' is reacted with acid to produce a compound of formula 6': CO 2 H HS C(O)NH N 5 H 6' or a salt or solvate thereof.
37. A process in accordance with claim 32 in which 10 trialkyl or triarylphosphines is optionally added.
38. A process in accordance with claim 33 in which the trialkylphosphine is tri-n-butylphosphine. 15
39. A process in accordance with claim 32 in which a solvent selected from the group consisting of C 1 . 5 alcohols, C1-3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others is optionally added. 20
AU82821/98A 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates Ceased AU731586B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5203297P 1997-07-09 1997-07-09
US60/052032 1997-07-09
GB9810184 1998-05-13
GBGB9810184.3A GB9810184D0 (en) 1998-05-13 1998-05-13 Process for synthisizing carbapenem side chain intermediates
PCT/US1998/013738 WO1999002531A1 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Publications (2)

Publication Number Publication Date
AU8282198A true AU8282198A (en) 1999-02-08
AU731586B2 AU731586B2 (en) 2001-04-05

Family

ID=26313663

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82821/98A Ceased AU731586B2 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Country Status (5)

Country Link
EP (1) EP1019411A4 (en)
JP (1) JP2002504156A (en)
AU (1) AU731586B2 (en)
CA (1) CA2294342C (en)
WO (1) WO1999002531A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
JP2003525297A (en) * 2000-03-01 2003-08-26 メルク エンド カムパニー インコーポレーテッド Crystal form of antibiotic side chain intermediate
ES2256311T3 (en) * 2000-11-20 2006-07-16 Sankyo Company, Limited PROCESSES FOR THE PREPARATION OF CARBAPENEM TYPE ANTIBACTERIAL AGENTS.
JP2008509909A (en) * 2004-08-11 2008-04-03 ウィリアムスバーグ・ホールディングス・エルエルシー Non-cardiotoxic pharmaceutical compounds
WO2010073706A1 (en) * 2008-12-25 2010-07-01 株式会社カネカ Improved process for producing intermediate for side chain of carbapenem
CN106565579A (en) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 Ertapenem side chain production technology

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP3091297B2 (en) * 1992-01-10 2000-09-25 住友製薬株式会社 Pyrrolidine derivative and method for producing the same
PT842166E (en) * 1995-08-04 2001-04-30 Merck & Co Inc PROCESS FOR SYNTHETIZING CARBAPENEM SIDE CHAIN INTERMEDIARIES

Also Published As

Publication number Publication date
EP1019411A4 (en) 2003-08-13
AU731586B2 (en) 2001-04-05
JP2002504156A (en) 2002-02-05
EP1019411A1 (en) 2000-07-19
WO1999002531A1 (en) 1999-01-21
CA2294342A1 (en) 1999-01-21
CA2294342C (en) 2006-03-14

Similar Documents

Publication Publication Date Title
KR100231223B1 (en) Azetidinone compound and process for preparation thereof
AU731586B2 (en) Process for synthesizing carbapenem side chain intermediates
WO2007104219A1 (en) A process for the preparation of the intermediate of β-methyl carbapenem
AU605491B2 (en) Quaternary amine thiol process
US6063931A (en) Process for synthesizing carbapenem side chain intermediates
CA2227696C (en) Process for synthesizing carbapenem side chain intermediates
US6060607A (en) Process for synthesizing carbapenem side chain intermediates
KR950013578B1 (en) Novel reactive thiophosphate derivatives of thia(dia)zole acetic acid and process for preparing the same
US5648501A (en) Process for synthesizing carbapenem side chain intermediates
GB2257703A (en) Acylation of 7 - amino-cephems
EP0679652B1 (en) Process for preparing carbapenem compounds
KR101031143B1 (en) Novel Intermediate for Carbapenem Compound for Oral Administration and Process for Producing the Same
US5721368A (en) Process for synthesizing carbapenem side chain intermediates
KR20050086548A (en) Process for producing carbapenem compound for oral administration
US5580976A (en) Preparation of β-lactam compounds, and intermediates therefor
KR100298922B1 (en) Method for preparing 4-substituted azetidinone derivatives
US5563264A (en) Preparation of βlactam compounds
JP2696807B2 (en) Preparation of carbapenem derivatives
CS83392A3 (en) Novel 4-substituted azetidinones as precursors of 2-substituted2-carboxycarbapenem antibiotics and process for preparing thereof
KR100650207B1 (en) Glutaryl 7-amino-3-vinyl-cephalosporanic acid derivatives and process for preparing it
US20060281918A1 (en) Resolution of enantiomeric mixtures of beta-lactams
JPH08283267A (en) Carbapenem-based compound and its production

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)